IFNA1 and depressive symptom measurement: The model for IFN- α-induced depression reveals the increases of pro-inflammatory cytokines both in the periphery and in the brain of patients, with subsequent activation of the indoleamine 2,3-dioxygenase (IDO) pathway and the production of potentially depressogenic tryptophan metabolites, such as quinolinic acid [83].